Abstract The rising of a highly aggressive subtype of castration-resistant prostate cancer (CRPC) named treatment-induced neuroendocrine prostate cancer (t-NEPC) after androgen deprivation therapy (ADT) is well known for its features of the neuroendocrine differentiation (NED) and androgen receptor (AR) independence. However. t-NEPC is still largely unknown. Here. https://www.diegojavierfares.com/mega-choice-Seattle-Seahawks-NFL-Printed-Camo-Socks-p11205-top-buy/